Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943).
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001786:Blood Glucose / Q000032:analysis; D002854:Chromatography, Paper; D006224:Cricetinae; D003630:Daunorubicin / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000633:toxicity; D004562:Electrocardiography; D004798:Enzymes / Q000097:blood; D000882:Haplorhini; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008251:Macaca; D008297:Male; D009206:Myocardium / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D011407:Propane / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D013154:Spleen / Q000378:metabolism; D013997:Time Factors
D000970:Antineoplastic Agents; D001786:Blood Glucose; D004798:Enzymes; D010879:Piperazines; D011407:Propane; D003630:Daunorubicin